The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Abstract
We assessed tumor cell DNA content (ploidy) and N-myc gene copy number as predictors of long-term disease-free survival in 298 children with neuroblastoma. Diploid tumor stem lines were identified in 101 patients (34%), clonal hyperdiploid abnormalities in 194 (65%), and hypodiploid stem lines in three (1%). In children with widely disseminated tumors at diagnosis (stage D), ploidy had a highly age-dependent influence on prognosis. Among infants (less than 12 months) treated with cyclophosphamide-doxorubicin, hyperdiploidy was closely associated with long-term disease-free survival (greater than 90% of cases), while diploidy invariably predicted early treatment failure (P less than .001). Similarly, in children 12 to 24 months of age who were treated with cisplatin-teniposide and cyclophosphamide-doxorubicin, diploidy uniformly predicted early failure, whereas half of the children with hyperdiploidy achieved long-term disease-free survival (P less than .001). There was no relationship between ploidy and treatment outcome in children older than 24 months with stage D tumors who had a very low probability of long-term disease-free survival (less than 10%). N-myc gene amplification was detected in 37 (25%) of the 147 tumors tested, with the remainder showing single-copy levels of the gene. N-myc gene amplification was more frequent in diploid than in hyperdiploid tumors (23 of 57 v 14 of 87, P = .001) and predicted a high likelihood of early treatment failure. In children younger than 2 years with disseminated neuroblastoma, tumor cell ploidy and N-myc gene copy number provide complementary prognostic information that will distinguish patients who can be cured on current regimens from those who require new treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Self-citationAssociation of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
Self-citationSchwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
Self-citationA proposed staging for children with neuroblastoma.Children's cancer study group A
Evans, A. E., D'Angio, G. J., & Randolph, J. (1971) · Cancer · doi:10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g · Cited by 950
Shimada, H., Chatten, J., Newton, W. A., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., & Misugi, K. (1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.2.405 · Cited by 862
Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
Self-citationFong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., & Brodeur, G. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3753 · Cited by 396
Self-citationCytogenetic features of human neuroblastomas and cell lines.
Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L., & Tsiatis, A. A. (1981) · PubMed · Cited by 383
Self-citationPrognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
Look, A., Roberson, P., Williams, D., Rivera, G., Bowman, W., Pui, C., Ochs, J., Abromowitch, M., Kalwinsky, D., & Dahl, G. (1985) · Blood · doi:10.1182/blood.v65.5.1079.1079 · Cited by 251
Self-citationCytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1
Hayashi, Y., Kanda, N., Inaba, T., Hanada, R., Nagahara, N., Muchi, H., & Yamamoto, K. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<126::aid-cncr2820630120>3.0.co;2-z · Cited by 182
Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study.
Nitschke, R., Smith, E. I., Shochat, S. J., Altshuler, G. P., Travers, H., Shuster, J. J., Hayes, F. A., Patterson, R., & McWilliams, N. B. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1271 · Cited by 143
Self-citationFinklestein, J. Z., Klemperer, M. R., Evans, A. E., Bernstein, I. D., LEIKIN, S. L., McCreadie, S. R., Grosfeld, J. L., Hittle, R. E., Weiner, J. M., Sather, H. N., et al. (1979) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950060211 · Cited by 139
Serum ferritin as a guide to therapy in neuroblastoma.
HANN, H.-W. L., Levy, H. M., & Evans, A. E. (1980) · PubMed · Cited by 135
Cohn, S. L., RADEMAKER, A. W., Salwen, H. R., Franklin, W. A., González-Crussí, F., Rosen, S. T., & Bauer, K. D. (1990) · PubMed · Cited by 54
N-myc oncogene amplification and prognostic factorsof neuroblastoma in children
Nakagawara, A., Ikeda, K., Tsuda, T., & Higashi, K. (1987) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(87)80583-3 · Cited by 52
Cited by
Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V, Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., & Hedborg, F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1466 · Cited by 2,294
Self-citationNeuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Self-citationThe International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Self-citationNakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., & Brodeur, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281205 · Cited by 694
Self-citationMolecular Biology of Neuroblastoma
Maris, J. M., & Matthay, K. K. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2264 · Cited by 639
Metadata
- Authors
- Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I., & Brodeur, G. M.
- Venue
- Journal of Clinical Oncology
- Published
- 1991-04
- Volume
- 9
- Issue
- 4
- Pages
- 581-591
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2101603147
- Cited by
- 594
- References
- 18
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.